Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway: Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version
December 9, 2020

Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway: Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version

By Matsuoka
Background: The rise within the variety of most cancers circumstances and the evolution of most cancers care administration have turn out to be a big downside for the French well being care system, thereby making affected person empowerment as a protracted sought-after purpose in continual pathologies. The implementation of an activation measure through the Affected person Activation Measure-13 merchandise (PAM-13) in the midst of most cancers care can probably spotlight the affected person’s wants, with nursing care adapting accordingly.
Goal: The goals of this PARACT (PARAmedical Interventions on Affected person ACTivation) multicentric research have been as follows: (1) consider the implementation of PAM-13 in oncology nursing practices in 5 complete most cancers facilities, (2) determine the obstacles and facilitators to the implementation of PAM-13, and (3) produce suggestions for the dissemination of such interventions in different complete most cancers facilities.
Strategies: This research will comply with the “Attain, Effectiveness, Adoption, Implementation, and Upkeep” framework and can consist of three phases. First, a strong preimplementation evaluation will probably be performed utilizing the Theoretical Domains Framework (TDF) linked to the “Functionality, Alternative, Motivation, and Conduct” mannequin to determine the obstacles and facilitators to implementing new nursing practices in every context. Then, utilizing the Conduct Change Wheel, we are going to personalize a technique for implementing the PAM-13, relying on the specificities of every context, to encourage acceptability by the nursing employees concerned within the mission. This evaluation will probably be carried out through a qualitative research by way of semistructured interviews.
Second, the affected person will probably be included within the research for 12 months, throughout which the affected person care pathway will probably be studied, significantly to gather all related contacts of oncology nurses and different well being professionals concerned within the pathway. The axes of nursing care may even be collected. The first purpose is to implement PAM-13. Secondary elements to be measured are the affected person’s nervousness stage, high quality of life, and well being literacy stage. The oncology nurses will probably be liable for finishing the questionnaires when the affected person is on the hospital for his/her intravenous chemotherapy/immunotherapy remedy. The questionnaires will probably be accomplished thrice in a 12 months: (1) on the time of the affected person’s enrollment, (2) at 6 months, and (3) at 12 months. Third, a postimplementation evaluation will probably be carried out by way of semistructured interviews utilizing the TDF to research the implementation issues at every website.
Outcomes: This research was supported by a grant from the French Ministry of Well being (PHRIP PARACT 2016-0405) and the Lucien Neuwirth Institute of Cancerology of Saint-Etienne, France. Knowledge assortment for this research is ongoing.
Conclusions: This research would enhance the carried out focused nursing interventions in most cancers facilities so {that a} affected person is obtainable a customized most cancers care pathway. Moreover, measuring the extent of activation and the implementation of measures meant to extend such activation may represent a big benefit in decreasing social well being inequalities.

Navigating uncharted waters: Creating a standardized method for evaluating and implementing biosimilar merchandise at a complete most cancers middle

Goal: The processes for formulary implementation and digital well being file (EHR) integration of biosimilar merchandise at a complete most cancers middle are described. Implications for analysis protocols are additionally mentioned.
Abstract: The present literature focuses on sensible concerns for formulary addition of biosimilar merchandise, however there’s a lack of steering on how you can implement the change, significantly throughout the EHR. Earlier than constructing the ordering instruments for biosimilars, the scientific and informatics groups ought to decide the function of biosimilars on the establishment, determine drug-specific product traits that have an effect on treatment construct, and characterize implications of future formulary adjustments or drug shortages. Leveraging an orderable file supplies the power to incorporate logic that maps to a number of merchandise and in addition permits for future implementation of adjustments throughout the treatment file fairly than requiring “swaps” on the remedy protocol stage. The institutional overview board ought to coordinate adjustments in affected analysis protocols and consent kinds and work with principal investigators to amend protocols when obligatory. Pharmacy leaders ought to develop processes to supervise stock in the course of the transition interval and decrease the chance of errors.
Conclusion: The event of a standardized method for evaluating and implementing biosimilar merchandise improves effectivity and collaboration among the many numerous group members liable for the merchandise’ integration into present workflows, together with implications for scientific analysis. Implementing biosimilars for brokers used to deal with most cancers will pose new challenges and require extra concerns. Partial implementation of biosimilars continues to pose a number of challenges within the provision of affected person care.
Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway: Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version

Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway: Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version

Matrix stiffness epigenetically regulates the oncogenic activation of the Sure-associated protein in gastric most cancers

In lots of cancers, tumour development is related to elevated tissue stiffness. But, the mechanisms associating tissue stiffness with tumorigenesis and malignant transformation are unclear. Right here we present that in gastric most cancers cells, the stiffness of the extracellular matrix reversibly regulates the DNA methylation of the promoter area of the mechanosensitive Sure-associated protein (YAP). Reciprocal interactions between YAP and the DNA methylation inhibitors GRHL2, TET2 and KMT2A may cause hypomethylation of the YAP promoter and stiffness-induced oncogenic activation of YAP.
BSA (Standard Grade)
30-AB70 1 kg
EUR 899
Description: Standard Grade Bovine Serum Albumin (99% pure)
Gastrointestinal Cancer Antigen (CA 19-9), antigen grade
CA1991-N-10 10 KU
EUR 529
Human Cancer Antigen 15-3 (CA 15-3) ELISA Kit
PRB-5069 96 assays
EUR 572
Human Cancer Antigen 15-3 (CA 15-3) ELISA Kit
PRB-5069-5 5 x 96 assays
EUR 2283
Cancer Antigen 15-3 MUC 1 Antigen (Human Milk)
VAng-Cr3871-10kU 10 kU
EUR 421
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.
Paraffin Tissue Section - Human Breast Tumor: Lobular carcinoma
T2235086-3 5 slides
EUR 257
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Breast Cancer-Associated Antigen BRCAA1 (BRCAA1) Antibody
20-abx148333
  • EUR 425.00
  • EUR 342.00
  • 100 ug
  • 50 ug
  • Shipped within 5-10 working days.
Cancer Antigen 15-3 MUC 1 Antigen (Human Ascites Fluid)
VAng-Cr3872-10kU 10 kU
EUR 1136
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Ascites Fluid.
Cancer Antigen CA 15-3 Protein (Human Fluids)
VAng-Wyb8628-inquire inquire Ask for price
Description: CA 15-3 (Breast Cancer Antigen), Cancer antigen from Human Fluids, 12.240 kU/mL.
Cancer Antigen CA 15-3 Protein (Human Milk)
VAng-Wyb8631-inquire inquire Ask for price
Description: CA 15-3 (Breast Cancer Antigen), Antigen Grade, Cancer antigen from Human Milk, 33.0 kIU/mL.
Paraffin Tissue Section - Human Brain Tumor: Astrocytoma Grade III
T2235035-3 5 slides
EUR 257
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Cancer Antigen 15-3 (CA15-3) (human) ELISA Kit
K4804-100 100 assays
EUR 834
  • Kit components:
  • CA15-3 Ab-coated Microplate (Item A), 96 wells
  • Wash Buffer (20x) (Item B)
  • Human CA15-3 Standard (Item C)
  • Assay Diluent A (Item D)
  • Assay Diluent B (5x) (Item E)
  • Detection Antibody (Item F)
  • HRP-Streptavidin (200x) (Item
  • Show more
Description: Sensitive, Colorimetric Assay
Breast Cancer Exosome
P141-BR NULL
EUR 0
Human Cancer PrimaCell4: Breast Tumor Cells Growth Medium
9-46027 5 x 100 ml Ask for price
Proteinase K, Recombinant, Standard Grade
9250-100
EUR 104
Proteinase K, Recombinant, Standard Grade
9250-10G
EUR 3856
Proteinase K, Recombinant, Standard Grade
9250-1G
EUR 457
Proteinase K, Recombinant, Standard Grade
9250-500
EUR 262
Proteinase K, Recombinant, Standard Grade
9251-100
EUR 1055
Proteinase K, Recombinant, Standard Grade
9251-25
EUR 294
Proteinase K, Recombinant, Standard Grade
9251-5
EUR 120
Fluorescent Exosome Standard (Urine )
ESF-15 100 µg
EUR 1723
Description: Fluorescent exosomes are labeled with green dye, which offer a stable fluorescent labeling.
Human Cancer Tissue Preparation Buffer 4: Breast Tumor Cells
9-80027 1 x 100 ml Ask for price
Breast Cancer Exosome RNA
P241-BR NULL
EUR 0
Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
DLR-CA15-3-Hu-48T 48T
EUR 479
  • Should the Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Carbohydrate Antigen 15-3 (CA15-3) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
DLR-CA15-3-Hu-96T 96T
EUR 621
  • Should the Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit is proven to show malperformance, you will receive a refund or a free replacement.
Description: A sandwich quantitative ELISA assay kit for detection of Human Carbohydrate Antigen 15-3 (CA15-3) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.
Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RDR-CA15-3-Hu-48Tests 48 Tests
EUR 500
Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RDR-CA15-3-Hu-96Tests 96 Tests
EUR 692
Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RD-CA15-3-Hu-48Tests 48 Tests
EUR 478
Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RD-CA15-3-Hu-96Tests 96 Tests
EUR 662
Polystyrene Particle Size Standard
PPS-3 mL
EUR 127
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone.
Inactivated MuV Grade 3 Antigen
VAng-Lsx0411-inquire inquire Ask for price
Description: MuV grade 3, native protein.
Inactivated Rotavirus Grade 3 Antigen
VAng-Lsx0469-inquire inquire Ask for price
Description: Rotavirus Grade 3, native virus.
Inactivated RuV Grade 3 Antigen
VAng-Lsx0476-1mL 1 mL
EUR 395
Description: RuV Grade 3, natural protein.
Inactivated CMV Grade 3 Antigen
VAng-Lsx0038-1mg 1 mg
EUR 2086
Description: CMV Grade 3, natural protein.
99445-15 DCT 15 X 85MM
99445-15 250/pk
EUR 97
Description: Disposable Culture Tubes; DCT's, CGW
CA 15-3, Human Breast Adenocarcinoma
P1435-1
EUR 109
CA 15-3, Human Breast Adenocarcinoma
P1435-5
EUR 240
Cancer Antigen 242 Antigen
VAng-Cr3876-10kU 10 kU
EUR 421
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration.
Cancer Antigen 50 Antigen
VAng-Cr3877-50kU 50 kU
EUR 5535
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.
Breast Cancer Metastasis Suppressor 1
PR27265 2 ug
EUR 191
Human CA15-3 Antigen Grade Protein
abx060972-250kU 250 kU
EUR 1984
  • Shipped within 5-10 working days.
Inactivated PIV-3 Grade 2 Antigen
VAng-Wyb3637-1mL 1 mL
EUR 1136
Description: Parainfluenza virus type 3 (strain C243) Grade 2, natural antigen
Inactivated HSV-1 Grade 3 Antigen
VAng-Lsx0293-1mg 1 mg
EUR 1489
Description: HSV Type 1 Grade III, native antigen.
Inactivated HSV-2 Grade 3 Antigen
VAng-Lsx0302-1mg 1 mg
EUR 1489
Description: HSV Type 2 Grade III, native antigen.
Breast Tumor Kinase antibody
70R-31875 100 ug
EUR 327
Description: Rabbit polyclonal Breast Tumor Kinase antibody
Breast Tumor Kinase antibody
70R-33385 100 ug
EUR 327
Description: Rabbit polyclonal Breast Tumor Kinase antibody
Breast Tumor Kinase Antibody
AF4768 200ul
EUR 376
Description: Breast Tumor Kinase Antibody detects endogenous levels of Breast Tumor Kinase.
Human Breast Tumor lysate
HTL-1323 1 mg
EUR 773
Vitamin A Reference Standard (USP grade powder)
51R-U716002 10 pack
EUR 516
Description: Vitamin A Reference Standard (USP grade powder) chemical reference substance
CEA Antigen Grade Protein
abx060976-05mg 0.5 mg
EUR 968
  • Shipped within 5-10 working days.
CEA Antigen Grade Protein
abx060977-1mg 1 mg
EUR 1692
  • Shipped within 5-10 working days.
Prostate Specific Antigen Std Grade Antigen
VAng-Cr3891-1mg 1 mg
EUR 504
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation.
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
abx025588-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
abx025588-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.
Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx129227
  • EUR 425.00
  • EUR 133.00
  • EUR 1205.00
  • EUR 578.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
20-abx133658
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.
Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx171475
  • EUR 857.00
  • EUR 439.00
  • 1 mg
  • 200 ug
  • Please enquire.
Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
20-abx013807
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.
Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx324781
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug
  • Shipped within 5-10 working days.
Recombinant Breast Cancer Anti-Estrogen Resistance 3 (BCAR3)
4-RPG768Hu01
  • EUR 501.41
  • EUR 237.00
  • EUR 1605.28
  • EUR 601.76
  • EUR 1103.52
  • EUR 398.00
  • EUR 3863.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: O75815
  • Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 60.7kDa
  • Isoelectric Point: Inquire
Description: Recombinant Human Breast Cancer Anti-Estrogen Resistance 3 expressed in: E.coli
Cancer Antigen 72-4 Antigen
VAng-Cr3878-10kU 10 kU
EUR 421
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.
Autobioluminescent Human Breast Cancer Cells (MCF7)
ASE-5903 1 ml
EUR 2075
Description: 6 month
Autobioluminescent Human Breast Cancer Cells (T47D)
ASE-5904 1 ml
EUR 2075
Description: 6 month
Breast Cancer Metastasis Suppressor 1 Protein
20-abx263402
  • EUR 1609.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 10 ug
  • 2 µg
  • Shipped within 5-10 working days.
Human Breast Cancer Signaling Primer Library
HBRCA-I 1 set
EUR 548
Breast Cancer Anti-Estrogen Resistance 1
PR27245 2 ug
EUR 191
Anti-Breast Cancer Resistance Protein antibody
STJ16100903 1 mL
EUR 478
Anti-Breast Cancer Resistance Protein antibody
STJ16100916 1 mL
EUR 478
anti-Breast cancer suppressor candidate 1
YF-PA12974 50 ul
EUR 363
Description: Mouse polyclonal to Breast cancer suppressor candidate 1
anti-Breast cancer suppressor candidate 1
YF-PA12975 50 ug
EUR 363
Description: Mouse polyclonal to Breast cancer suppressor candidate 1
anti-Breast cancer suppressor candidate 1
YF-PA24096 50 ul
EUR 334
Description: Mouse polyclonal to Breast cancer suppressor candidate 1
Human Cancer Antigen CA15-3 Protein
abx060965-50kU 50 kU
EUR 2625
  • Shipped within 5-10 working days.
9998 SCREW CAP 415/15
9998-15 288/pk
EUR 198
Description: General Apparatus; Stoppers
Breast Tumor Tissue Array - 16 cases of breast cancer, each in duplicates, paired with adjacent normal tissues
Z7020007 5 slides
EUR 1381
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Inactivated MuV Grade 3 Antigen (Strain Enders)
VAng-0619Lsx-inquire inquire Ask for price
Description: MuV (Strain Enders) grade 3, native protein. 0.45 mg/mL.
Standard grade heat shock BSA powder, pH 7
BAH62-0050 50gm
EUR 257.4
  • Standard grade heat shock BSA powder, pH 7 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 7
BAH62-0100 100gm
EUR 323.7
  • Standard grade heat shock BSA powder, pH 7 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 7
BAH62-0500 500gm
EUR 426.4
  • Standard grade heat shock BSA powder, pH 7 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 7
BAH62-1000 1KG Ask for price
  • Standard grade heat shock BSA powder, pH 7 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 7
BAH62-10000 10KG Ask for price
  • Standard grade heat shock BSA powder, pH 7 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 5.2
BAH63-0050 50gm
EUR 257.4
  • Standard grade heat shock BSA powder, pH 5.2 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 5.2
BAH63-0100 100gm
EUR 323.7
  • Standard grade heat shock BSA powder, pH 5.2 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 5.2
BAH63-0500 500gm
EUR 426.4
  • Standard grade heat shock BSA powder, pH 5.2 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 5.2
BAH63-1000 1KG Ask for price
  • Standard grade heat shock BSA powder, pH 5.2 is indicated as RUO. Do not use on humans.
Standard grade heat shock BSA powder, pH 5.2
BAH63-10000 10KG Ask for price
  • Standard grade heat shock BSA powder, pH 5.2 is indicated as RUO. Do not use on humans.
Breast Tumor Kinase antibody (Tyr447)
70R-33384 100 ug
EUR 327
Description: Rabbit polyclonal Breast Tumor Kinase antibody (Tyr447)
Breast Tumor Kinase Blocking Peptide
AF4768-BP 1mg
EUR 195
Human Tumor Tissue: Breast cDNA
HT05-090 10 rxn
EUR 415
Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
abx010337-100ug 100 ug
EUR 439
  • Shipped within 5-10 working days.
Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
abx218562-100ug 100 ug
EUR 439
  • Shipped within 5-10 working days.
Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
20-abx134976
  • EUR 356.00
  • EUR 537.00
  • EUR 217.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.
Human Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Protein
20-abx168253
  • EUR 704.00
  • EUR 286.00
  • EUR 2165.00
  • EUR 829.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Cancer of the breast, 75 cases (1.1mm), set 3
BRC1503 1
EUR 250
Description: Breast cancer tissue array, set 3, non-overlapping with BRC1501, BRC1502, BRC1504 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.
Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
abx432398-200ul 200 ul
EUR 384
  • Shipped within 1-3 working days.
Breast Cancer Estrogen Resistance 3 (BCAR3) Polyclonal Antibody (Human)
4-PAG768Hu01
  • EUR 247.00
  • EUR 2510.00
  • EUR 625.00
  • EUR 310.00
  • EUR 214.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: BCAR3 (Asp548~Pro818)
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Breast Cancer Estrogen Resistance 3 (BCAR3)
Cancer Antigen CEA Antigen (Human Fluids)
VAng-Wyb8644-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL.
Cancer Antigen 125 Antigen (Human Adenocarcinoma)
VAng-Cr3868-10kU 10 kU
EUR 421
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography.
Cancer Antigen 125 Antigen (Ascites Fluid)
VAng-Cr3870-10kU 10 kU
EUR 944
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE.
ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen grade
ODNM362-1 1 mg
EUR 651
ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen grade
ODNM362-5 5 mg
EUR 1991
Human Cancer Antigen CA125 (Ovarian Cancer) Protein
abx061590-100kU 100 kU
EUR 1205
  • Shipped within 5-10 working days.
Ck-Mm Antigen Grade Protein
abx060710-1mg 1 mg
EUR 648
  • Shipped within 5-10 working days.
Human AFP Antigen Grade Protein
abx060957-1mg 1 mg
EUR 926
  • Shipped within 5-10 working days.
Human AFP Antigen Grade Protein
abx060958-1mg 1 mg
EUR 1316
  • Shipped within 5-10 working days.
Human AFP Antigen Grade Protein
abx060959-1mg 1 mg
EUR 996
  • Shipped within 5-10 working days.
Human CA125 Antigen Grade Protein
abx060960-50kU 50 kU
EUR 801
  • Shipped within 5-10 working days.
Imidazoquinoline (TLR7 Agonist) Antigen Grade
VAdv-Ly0018-25mg 25 mg
EUR 3610
Description: Imidazoquinoline, a TLR7 agonist vaccine adjuvant.
Imidazoquinoline (TLR7 Agonist) Antigen Grade
VAdv-Ly0018-5mg 5 mg
EUR 861
Description: Imidazoquinoline, a TLR7 agonist vaccine adjuvant.
Recombinant CEA Protein (Antigen Grade)
VAng-Wyb8647-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Antigen Grade, recombinant protein from Cell Culture, 3.71 mg/mL.
Inactivated VZV Grade 2 Antigen
VAng-Lsx0555-inquire inquire Ask for price
Description: VZV Grade 2, native virus.
Inactivated MeV Grade 2 Antigen
VAng-Lsx0384-inquire inquire Ask for price
Description: Measles Grade 2, native virus.
Inactivated MuV Grade 2 Antigen
VAng-Lsx0409-inquire inquire Ask for price
Description: MuV Grade 2, native virus.
Inactivated RuV Grade 2 Antigen
VAng-Lsx0475-inquire inquire Ask for price
Description: RuV Grade 2, natural protein.
Inactivated RuV Grade 4 Antigen
VAng-Lsx0477-1mg 1 mg
EUR 3080
Description: RuV Grade 4, natural antigen.
Inactivated CMV Grade 2 Antigen
VAng-Lsx0037-1mg 1 mg
EUR 2027
Description: CMV Grade 2, natural protein.
Inactivated ADV Grade 2 Antigen
VAng-Lsx0003-1mL 1 mL
EUR 998
Description: ADV Grade 2, natural antigen.
Recombinant (E. coli) Dengue Virus Type 3 E Antigen (DENV-E), antigen grade (>95%, 15 kda, no tag)
RP-1596 50 ug
EUR 408
Paraffin Tissue Section - Human Breast Tumor: Male Breast Hyperplasia
T2235086-4 5 slides
EUR 257
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Paraffin Tissue Section - Human Breast Tumor: Medullarycarcinoma of Breast
T2235086-5 5 slides
EUR 257
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Recombinant Human IL-15 Protein
PROTP40933-3 10ug
EUR 317
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowel disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues.
Swine IL-15 Recombinant Protein
R00212-3 5ug/vial
EUR 259
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Swine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast.
Paraffin Tissue Section - Human Pancreas Tumor: Islet Cell Tumor
T2235188-3 5 slides
EUR 257
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.
Breast cancer-overexpressed gene 1 protein Antibody
48092-100ul 100ul
EUR 333
Breast cancer-overexpressed gene 1 protein Antibody
48092-50ul 50ul
EUR 239
Human Breast cancer metastasis-suppressor 1 (BRMS1)
1-CSB-RP048144h
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
  • MW: 54.3 kDa
  • Buffer composition: Tris-based buffer with 50% glycerol.
Description: Recombinant Human Breast cancer metastasis-suppressor 1(BRMS1),partial expressed in E.coli
Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx008216
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.
Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx008217
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx175628
  • EUR 1177.00
  • EUR 578.00
  • 1 mg
  • 200 ug
  • Please enquire.
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx104049
  • EUR 411.00
  • EUR 133.00
  • EUR 1149.00
  • EUR 565.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx104050
  • EUR 439.00
  • EUR 133.00
  • EUR 1247.00
  • EUR 592.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx104051
  • EUR 411.00
  • EUR 133.00
  • EUR 1149.00
  • EUR 565.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx129675
  • EUR 425.00
  • EUR 133.00
  • EUR 1177.00
  • EUR 578.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx129746
  • EUR 300.00
  • EUR 133.00
  • EUR 801.00
  • EUR 425.00
  • EUR 258.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx130340
  • EUR 439.00
  • EUR 133.00
  • EUR 1233.00
  • EUR 592.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.
Breast Cancer Cell Protein 2 (BRCC2) Antibody
20-abx141388
  • EUR 370.00
  • EUR 606.00
  • EUR 300.00
  • 100 ul
  • 200 ul
  • 50 ul
  • Shipped within 5-10 working days.
Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx171476
  • EUR 815.00
  • EUR 425.00
  • 1 mg
  • 200 ug
  • Please enquire.
Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx171477
  • EUR 815.00
  • EUR 425.00
  • 1 mg
  • 200 ug
  • Please enquire.
Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
abx030985-400ul 400 ul
EUR 523
  • Shipped within 5-10 working days.
Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
abx030985-80l 80 µl
EUR 286
  • Shipped within 5-10 working days.
Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx241361
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.
Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx241362
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.
Direct alteration of extracellular cues through in situ matrix softening reversed YAP exercise and the epigenetic program. Our findings recommend that epigenetic reprogramming of the mechanophysical properties of the extracellular microenvironment of stable tumours might symbolize a therapeutic technique for the inhibition of most cancers development.